Risks of BP lowering drugs before joint replacement surgery may outweigh the benefits


The long-standing controversy around whether to continue or withhold renin angiotensin antagonists (RAAs) before non-cardiac surgery has chalked up new evidence that favours withholding the therapy before an operation. Doctors at the Princess Alexandra hospital in Queensland found that patients undergoing elective joint replacements who were receiving RAAs in the lead up to their surgery ...


Already a member? Login to keep reading


OR
© 2017 the limbic